HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Craig J Thomas Selected Research

Lymphoma (Lymphomas)

12/2017Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
12/2010Cooperative epigenetic modulation by cancer amplicon genes.
1/2010Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Craig J Thomas Research Topics

Disease

51Neoplasms (Cancer)
06/2022 - 03/2005
5Rhabdomyosarcoma
01/2021 - 08/2013
5Breast Neoplasms (Breast Cancer)
11/2018 - 01/2006
4Carcinogenesis
06/2022 - 10/2012
4Treatment-Resistant Depressive Disorder
11/2021 - 01/2019
4Prostatic Neoplasms (Prostate Cancer)
10/2020 - 01/2014
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 02/2014
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 06/2014
3Leukemia
01/2018 - 02/2011
3Lymphoma (Lymphomas)
12/2017 - 01/2010
3Lung Neoplasms (Lung Cancer)
11/2017 - 12/2011
3Schistosomiasis (Bilharziasis)
10/2009 - 01/2008
2Adenocarcinoma
01/2022 - 01/2022
2Bipolar Disorder (Manic Depressive Psychosis)
01/2022 - 01/2021
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2022 - 01/2021
2Major Depressive Disorder (Major Depressive Disorders)
01/2022 - 10/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 11/2019
2Neoplasm Metastasis (Metastasis)
01/2022 - 11/2019
2Ataxia Telangiectasia (Louis Bar Syndrome)
12/2021 - 12/2020
2Neuroblastoma
01/2021 - 11/2015
2Ewing Sarcoma (Sarcoma, Ewing)
01/2020 - 12/2017
2Tuberculosis (Tuberculoses)
12/2019 - 01/2016
2Glioma (Gliomas)
11/2019 - 01/2017
2Glioblastoma (Glioblastoma Multiforme)
01/2019 - 01/2017
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 12/2017
2Schizophrenia (Dementia Praecox)
01/2016 - 07/2012
2Marfan Syndrome (Marfan's Syndrome)
10/2015 - 04/2011
2Thyroid Neoplasms (Thyroid Cancer)
07/2010 - 07/2009
2Hyperthyroidism
07/2010 - 12/2008
1Rare Diseases (Rare Disease)
12/2022
1Substance-Related Disorders (Drug Abuse)
10/2022
1COVID-19
06/2022
1Neurofibrosarcoma (MPNST)
01/2022
1Neuralgia (Stump Neuralgia)
01/2022
1Complex Regional Pain Syndromes
01/2022
1Genomic Instability
12/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021
1Neuroinflammatory Diseases
01/2021

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
12/2022 - 01/2008
9EnzymesIBA
12/2021 - 03/2005
8Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2009
8Pyruvate KinaseIBA
01/2022 - 02/2010
8Protein Isoforms (Isoforms)IBA
01/2018 - 02/2010
7Phosphotransferases (Kinase)IBA
12/2020 - 05/2008
6EsketamineIBA
01/2022 - 10/2018
6Drug CombinationsIBA
12/2020 - 10/2012
5KetamineFDA LinkGeneric
10/2022 - 10/2018
4ibrutinibIBA
11/2021 - 02/2014
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2022 - 01/2018
3Antidepressive Agents (Antidepressants)IBA
01/2022 - 10/2018
3Type I DNA Topoisomerases (Topoisomerase I)IBA
12/2021 - 03/2005
3Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2017
3Histones (Histone)IBA
11/2019 - 12/2010
3DNA (Deoxyribonucleic Acid)IBA
09/2016 - 03/2005
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2015 - 01/2006
26-hydroxynorketamineIBA
10/2022 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 11/2018
2Agammaglobulinaemia Tyrosine KinaseIBA
11/2021 - 12/2017
2CytokinesIBA
01/2021 - 04/2015
2Interleukin-2 (IL2)IBA
01/2021 - 10/2015
2trametinibIBA
01/2021 - 01/2018
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020 - 08/2013
2Nicotinamide PhosphoribosyltransferaseIBA
01/2020 - 12/2017
2Glutamine (L-Glutamine)FDA Link
11/2018 - 10/2017
2GlutaminaseIBA
11/2018 - 11/2017
2Aspartic Acid (Aspartate)FDA Link
11/2018 - 11/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2017 - 12/2011
2ruxolitinibIBA
02/2016 - 10/2015
2navitoclaxIBA
02/2016 - 10/2015
2Neuregulin-1 (Neuregulin 1)IBA
01/2016 - 07/2012
2Interleukin-15 (Interleukin 15)IBA
10/2015 - 08/2013
21- (4- dimethylaminomethylphenyl)- 8,9- dihydro- 7H- 2,7,9a- benzo(cd)azulen- 6- oneIBA
06/2014 - 01/2006
2Biological ProductsIBA
07/2012 - 02/2011
2IsoenzymesIBA
11/2011 - 02/2010
2Tyrosine (L-Tyrosine)FDA Link
04/2011 - 12/2010
2tofacitinibIBA
04/2011 - 02/2011
2Thyrotropin Receptors (Thyrotropin Receptor)IBA
07/2010 - 12/2008
1SNX 2112IBA
06/2022
1Tyrosine Kinase InhibitorsIBA
06/2022
1SARS-CoV-2 3C-like proteinaseIBA
06/2022
1torinIBA
01/2022
1carfilzomibIBA
01/2022
1Methionine Sulfoxide ReductasesIBA
01/2022
1PanobinostatIBA
01/2022
1NexusIBA
01/2022
18- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA
01/2022
1Methionine (L-Methionine)FDA Link
01/2022
1adavosertibIBA
01/2022
1PlatinumIBA
12/2021
1Histocompatibility Antigens Class IIBA
12/2021
1Phospholipases (Phospholipase)IBA
11/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1ON 01910IBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1Vinca AlkaloidsIBA
01/2021
1upadacitinibIBA
01/2021

Therapy/Procedure

17Therapeutics
12/2022 - 01/2008
7Drug Therapy (Chemotherapy)
11/2019 - 03/2005
1Treatment Delay
01/2021